mRNA therapy found to prevent recurrence of melanoma
21 August, 2026Merck and Moderna have announced positive topline results from their Phase 3 trial of a personalised mRNA skin cancer therapy.
High doses of fertility drug linked to pregnancy risks
14 August, 2026High doses of clomiphene citrate, accumulated over multiple fertility treatment cycles, could increase the risk of pregnancy loss.
Bird flu vaccine to be rolled out to "priority" species
12 August, 2026 by Lauren DavisThe Australian Government has announced the imminent rollout of a vaccine to protect some of Australia's most vulnerable native birds from the H5 bird flu.
Breast augmentation procedure uses 3D-printed scaffolds
11 August, 20263D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast augmentation procedure at Macquarie University as part of a pivotal trial.
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
08 May, 2026Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies. Now, Australian scientists believe they've made it safer.
Ecopha Biotech announces strategic cross-border model
01 May, 2026To commercialise its ecopha.bio technology for a Pongamia-based bioeconomy, Australian company Ecopha Biotech has announced an Australia–India strategy.
$96m RNA Research and Manufacturing Facility opens in NSW
30 April, 2026The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct will produce new and existing RNA therapeutics.
Cartherics and Catalent announce enhanced partnership
23 April, 2026To support immune cell therapy products for the treatment of cancer and endometriosis, Australian biotech Cartherics has announced an enhanced partnership with Catalent.
CTA granted for CAR-T cell therapy for multiple myeloma
02 April, 2026The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell immunotherapy for multiple myeloma.
Whisper-quiet precision for modern analytical devices
01 April, 2026Bürkert's Whisper Valves are compact electromagnetic micro-valves designed for highly precise dosing and fluid control.
How Cell-Free Synthesis is Revolutionising Biotechnology
01 April, 2026As biotechnology evolves, innovations in DNA manufacturing may prove as essential as the discovery of DNA itself, enabling faster, safer, and more flexible research and development.
Sensor's cell-like structure said to overcome key blood-testing barrier
25 March, 2026Drawing inspiration from nature, Australian researchers have developed a sensor they believe overcomes one of the biggest barriers in blood testing.
Aussie biotech to manufacture mRNA paediatric brain cancer vaccines
05 March, 2026A Queensland-based biotechnology company will manufacture personalised mRNA paediatric brain cancer vaccines for a clinical trial commencing this month.
Could this biosensor bypass labs with onsite PFAS detection?
17 February, 2026La Trobe University has developed a portable biosensor that may allow rapid, onsite detection of toxic 'forever chemicals' in water.
Noxopharm says paper reveals science behind its immune system platform
13 February, 2026Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology paper reveals the science behind its immune system platform, Sofra.
